TOPIC: “Blocking Non-Melanoma Skin Cancer by Regulating Inflammatory Signaling Keratinocytes: Targeting Toll-like Receptor 4”
SPEAKER: Sally Dickinson, PhD | Research Assistant Professor (Cancer Biology and Pharmacology), Department of Pharmacology, University of Arizona College of Medicine – Tucson; member, UA Cancer Center
Wednesday, Sept. 26, 2018 | 9 a.m.
UA Cancer Center – 2920
(Bagels and coffee will be served.)
Click here to view, post and share the flyer for this event: cpc-seminar-with-dr.sally-dickinson_flyer_2018-09-26.pdf
Presentation Summary: Skin cancer is the most frequently diagnosed cancer in the United States, affecting one in five Americans by the age of 70. Our group aims to develop novel means to prevent and treat non-melanoma skin cancer, specifically focusing on the most deadly form of the disease, cutaneous squamous cell carcinoma (cSCC). It is well established that overstimulation of inflammation can be a contributing factor to the development of many forms of cancer, including cSCC. In this talk I will discuss our recent findings which indicate that targeting inflammatory stress signaling within skin keratinocytes (the progenitors of cSCC) using pharmacological inhibitors of Toll-like Receptor 4 (TLR4) can block UV-induced stress signaling and skin carcinogenesis..
If you wish to view this presentation at a later time, you may access the video at https://streaming.biocom.arizona.edu/home/ – Click on ‘Centers of Excellence” then “Arizona Cancer Center”; scroll to the date desired.
In addition, CPC Seminars are now available, via Zoom. Please follow the link https://zoom.us/j/6021215414 ... If you do not currently have zoom, you will be prompted to download the free app. Alternatively, you can open your zoom app and join the meeting with 6021215414
University of Arizona Cancer Center, Conf. Rm. 2920
Leon F. Levy Building
1515 N. Campbell Ave.
Tucson, AZ 85724